Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 22113945)

1.

Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells.

Okuda H, Kobayashi A, Xia B, Watabe M, Pai SK, Hirota S, Xing F, Liu W, Pandey PR, Fukuda K, Modur V, Ghosh A, Wilber A, Watabe K.

Cancer Res. 2012 Jan 15;72(2):537-47. doi: 10.1158/0008-5472.CAN-11-1678. Epub 2011 Nov 23.

2.

Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.

Udabage L, Brownlee GR, Waltham M, Blick T, Walker EC, Heldin P, Nilsson SK, Thompson EW, Brown TJ.

Cancer Res. 2005 Jul 15;65(14):6139-50.

3.

Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.

Urakawa H, Nishida Y, Wasa J, Arai E, Zhuo L, Kimata K, Kozawa E, Futamura N, Ishiguro N.

Int J Cancer. 2012 Jan 15;130(2):454-66. doi: 10.1002/ijc.26014. Epub 2011 Apr 25.

PMID:
21387290
4.

Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.

Li Y, Li L, Brown TJ, Heldin P.

Int J Cancer. 2007 Jun 15;120(12):2557-67.

PMID:
17315194
5.

Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).

Bernert B, Porsch H, Heldin P.

J Biol Chem. 2011 Dec 9;286(49):42349-59. doi: 10.1074/jbc.M111.278598. Epub 2011 Oct 20.

6.

Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis.

Chanmee T, Ontong P, Mochizuki N, Kongtawelert P, Konno K, Itano N.

J Biol Chem. 2014 Sep 19;289(38):26038-56. doi: 10.1074/jbc.M114.564120. Epub 2014 Jul 30.

PMID:
25077968
7.

HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.

Tofuku K, Yokouchi M, Murayama T, Minami S, Komiya S.

Int J Oncol. 2006 Jul;29(1):175-83.

PMID:
16773198
8.

miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.

Okuda H, Xing F, Pandey PR, Sharma S, Watabe M, Pai SK, Mo YY, Iiizumi-Gairani M, Hirota S, Liu Y, Wu K, Pochampally R, Watabe K.

Cancer Res. 2013 Feb 15;73(4):1434-44. doi: 10.1158/0008-5472.CAN-12-2037. Epub 2013 Feb 5.

9.

Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.

Hiraga T, Ito S, Nakamura H.

Cancer Res. 2013 Jul 1;73(13):4112-22. doi: 10.1158/0008-5472.CAN-12-3801. Epub 2013 Apr 30.

10.

Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy.

Cook AC, Chambers AF, Turley EA, Tuck AB.

J Biol Chem. 2006 Aug 25;281(34):24381-9. Epub 2006 Jun 28.

11.

4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.

Kultti A, Pasonen-Seppänen S, Jauhiainen M, Rilla KJ, Kärnä R, Pyöriä E, Tammi RH, Tammi MI.

Exp Cell Res. 2009 Jul 1;315(11):1914-23. doi: 10.1016/j.yexcr.2009.03.002. Epub 2009 Mar 13.

PMID:
19285976
12.

Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.

Lien HC, Lee YH, Jeng YM, Lin CH, Lu YS, Yao YT.

Histopathology. 2014 Sep;65(3):328-39. doi: 10.1111/his.12390. Epub 2014 Apr 2.

PMID:
24527698
13.

Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.

Urakawa H, Nishida Y, Knudson W, Knudson CB, Arai E, Kozawa E, Futamura N, Wasa J, Ishiguro N.

J Orthop Res. 2012 Apr;30(4):662-72. doi: 10.1002/jor.21557. Epub 2011 Sep 12.

PMID:
21913222
14.

CD44 attenuates metastatic invasion during breast cancer progression.

Lopez JI, Camenisch TD, Stevens MV, Sands BJ, McDonald J, Schroeder JA.

Cancer Res. 2005 Aug 1;65(15):6755-63.

15.

HAS2 and CD44 in breast tumorigenesis.

Heldin P, Basu K, Kozlova I, Porsch H.

Adv Cancer Res. 2014;123:211-29. doi: 10.1016/B978-0-12-800092-2.00008-3. Review.

PMID:
25081531
16.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
17.

The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.

Buijs JT, van der Horst G, van den Hoogen C, Cheung H, de Rooij B, Kroon J, Petersen M, van Overveld PG, Pelger RC, van der Pluijm G.

Oncogene. 2012 Apr 26;31(17):2164-74. doi: 10.1038/onc.2011.400. Epub 2011 Sep 26.

PMID:
21996751
18.

4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors.

Edward M, Quinn JA, Pasonen-Seppänen SM, McCann BA, Tammi RH.

Br J Dermatol. 2010 Jun;162(6):1224-32. doi: 10.1111/j.1365-2133.2010.09699.x. Epub 2010 Feb 15.

PMID:
20163414
19.

Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.

Bourguignon LY, Gilad E, Peyrollier K.

J Biol Chem. 2007 Jul 6;282(27):19426-41. Epub 2007 May 10.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk